Patient Capital Adds to QXO After 61% Drop From Highs
The strategy raised its QXO position by more than 70% since Q2 and says it may keep adding if the price stays in range.
Makkler Newsroom · Oct 12, 07:49 PM · 1 min read
Market closed· · USD · Data may be delayed
Avg. target $23.00 (+91.5%)
Prices may be delayed and are for informational purposes only - not investment advice.
Profitability and valuation from the filed statements
Answers from price, statements, peer and news data. Not investment advice.
MakklerAI Q&A is open to MakklerPRO members. Upgrade to MakklerPRO